Human Immune Responses to Yellow Fever Vaccination
Sponsor: Emory University
Listed as NCT00694655, this PHASE4 trial focuses on Yellow Fever and remains completed. Sponsored by Emory University, it has been updated 15 times since 2008, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Nov 2025 — Present [monthly]
Completed PHASE4
-
May 2025 — Nov 2025 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Sep 2024 — May 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
May 2024 — Jul 2024 [monthly]
Recruiting PHASE4
▶ Show 10 earlier versions
-
Jan 2024 — May 2024 [monthly]
Recruiting PHASE4
-
Jan 2023 — Jan 2024 [monthly]
Recruiting PHASE4
Status: Active Not Recruiting → Recruiting · Phase: NA → PHASE4
-
Nov 2021 — Jan 2023 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Nov 2021 [monthly]
Active Not Recruiting NA
-
Nov 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Nov 2018 — Nov 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
-
Feb 2017 — Oct 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
May 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Emory University
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institutes of Health (NIH)
For direct contact, visit the study record on ClinicalTrials.gov .